Coronavirus
Technology Solutions
Holistic Plan to
Battle COVID Now
TE Mask Bubbles
are the Best
Weapon to Defeat
COVID
Open Schools Now
Countries with
3.3 Billion
People will Only
Achieve a 10%
Vaccination Rate
by the End of
2021
______________________________________________________________________________
Holistic Plan to
Battle COVID Now
Office
buildings,
schools, gyms,
and other
facilities can
be immediately
reopened with
the right
holistic COVID
game plan.
Companies such
as Johnson
Controls,
Daikin, Mann +
Hummel along
with many others
have the weapons
to fight a full
scale battle
against COVID.
The challenge is
to use all the
weapons with a
holistic
approach.
Presently
the strategy is
more like one
used by Iran
against Iraq.
Just keep
sacrificing ill
equipped
soldiers
until
the war
is won
despite
the costs. Here
are the weapons
available.
Every military
manual advises
that people win
wars. Providing
people with
inefficient
cloth masks when
they could be
wearing TE 90
masks is
comparable to
swords vs M6
rifles.
If
everyone is
wearing a TE 90
mask then only
1% of the virus
is transmitted.
Room air
purifiers and
HVAC systems
have to be
designed around
mask quality and
practice. If one
is eating or
drinking the
mask is not
protective. To
avoid the
necessity of
wearing masks
all day the
individual can
be less
restricted when
in an area with
few intruders,
laminar air flow
and efficient
filters.
The concept can
be likened to a
pharmaceutical
cleanroom with
different levels
of
particle
removal.
Here are
the U.S. and ISO
ratings.
The wearing of
masks would be a
function of the
measured rating
in the area.
McIlvaine
has recorded
presentations on
ways to measure
and control air
quality in each
area. Particles
and CO2 are good
parameters. The
number of people
in an area can
also be
continuously
monitored.
In a
pharmaceutical
cleanroom there
will be ISO 3
biological
safety cabinet
in an ISO 7
space.
This
space may also
contain
ISO 5
isolators. The
building would
be maintained at
ISO 9 or better
and might have
several ISO 7
areas each of
which contains
more efficient
sub space.
In an office
building the
lobby could be
maintained at
ISO 9 with
everyone wearing
TE-90 masks 100%
of the time. The
elevator can be
kept at ISO 5
but with
everyone wearing
TE 90 masks due
to the close
quarter contact
with new people.
The upper floors
could be
maintained at
ISO 9 but with
some space
meeting ISO 7
and others
meeting ISO 5.
Mask wearing
would be a
function of the
actual
continuously
monitored CO2,
particulate, and
number of
people.
Lunchroom eating
areas and
special
conference rooms
would be
maintained at
ISO 5 and masks
could be removed
while eating or
drinking or
making a
presentation.
TE Mask Bubbles
are the Best
Weapon to Defeat
COVID
The value of
efficient masks
to defeat COVID
is
underestimated.
Efficient tight
fitting masks
can be made
available to
everyone. If
masks with net
efficiency
(media capture
minus air
leakage) of 90%
are worn by
transmitter and
recipient 99% of
the inhalation
is eliminated.
If the world
inhabitants were
wearing these
masks properly
the battle would
be won. Can this
be accomplished
and how? Here
are some
answers.
·
Sufficient
reusable
efficient tight
fitting masks
can be made
available in a
matter of just a
few months.
·
The problem of
obtaining a
proper fit can
be solved with
creative
thinking e.g.
each
fitness center
and large
clothing
retailer could
offer fit
testing advice
and service.
·
Local
governments
would allow
opening and
operation of
schools,
airlines, meat
processors, and
office buildings
based on the
bubble concept.
Each entrant
would have to
have what could
be called a TE
mask. TE stands
for tight
fitting and
efficient. This
could also be
labeled as an
ASTM 50 plus and
would follow the
testing
protocols laid
out by ASTM.
·
Since
90% net
efficient masks
are available
most governments
would want to
specify TE 90 or
TE 85
effectiveness
including fit
testing
protocols.
The TE 90 masks
if worn
correctly will
be more
effective than
vaccines.
Partitions are
no more
effective in
reducing virus
transmission
than they are
perfume or
cigarette smoke.
Cloth masks have
high air in
leakage and low
media
efficiency.
Highly efficient
air filters can
be very
effective but
many will be
less effective
because the
recipient is in
between the
transmitter and
filter.
The large near
term profits
will insure
availability of
the masks. The
long term market
will include 67
countries which
will not have
sufficient
vaccines until
2024. It will
also include
masks for
anti-air
pollution,
wildfires, and
health issues.
The
wealthy
countries may
have to
contribute to
insure adequate
funding in the
poorer countries
with 3.6 billion
people.
The wealthy
countries would
need 3 billion
masks per
quarter. But as
the vaccinations
take effect in
the third
quarter, the use
could start to
diminish. The
poorer countries
would be waiting
their turn and
would not
experience peak
purchases until
the second
quarter 2022.
The advantages
of tight fitting
masks for
protection
against air
pollution, new
variants of the
coronavirus,
influenza, and
wildfires would
be communicated
and the market
would steadily
grow. People
would wear masks
when they have
colds and adopt
the courtesy
customs of Asia.
The market would
grow modestly
after achieving
4 billion unit
sales in the
second quarter
2022 and then
eventually
stabilize around
3 billion units
with
modest
growth in future
years.
For COVID
mitigation in
the wealthy
countries the
peak need would
be 3 billion
masks per
quarter. At $30
per mask the
market would be
$90 billion by
third quarter
2021. At this
price the wearer
could procure a
Comfortable,
Attractive,
Tight Fitting
Efficient,
Reusable (CATER)
mask. When
compared to the
value of gym
shoes, hoodies
or other items
of clothing this
would be an
attractive
purchase.
The biggest
driver will be
the TE mask
bubbles. If the
individual with
a $100 per month
gym membership
needs a $30 mask
in order to use
the facility he
will not
hesitate.
Parents will
gladly pay for
$30 masks if
their children
can return to
school.
The problem
comes with the
cost for the 67
middle income
and poor
countries. The
big variable is
the length of
use. What if a
mask could be
used for 1 year?
It might
not look as nice
in month 12 but
how would it
function
otherwise?
Here is a
guesstimate.
This graph is
for a CATER 95
mask which is a
version of TE
90. There would
be a big
deterioration in
attractiveness.
Comfort would
likely not
deteriorate
much. The net
efficiency which
includes media
capture less air
in leakage might
deteriorate from
90% to 70% but
it would still
be much better
than a cloth
mask. When you
consider that
there are more
people walking
around with used
Michael Jordan
shirts in Africa
then people in
the U.S. wearing
new ones this
scenario seems
reasonable.
Open Schools Now
We are proposing
that each school
create a TE 90
bubble. Everyone
who enters the
campus would be
required to wear
a tight fitting
efficient mask.
Universities
could lead the
way.
Here is an
opportunity
which will
result in 100 %
opening of
universities and
make them
technology
leaders in the
COVID battle.
As you can see
from the
calculations if
everyone is
wearing a tight
fitting
efficient mask
(0.9 x + 0.9 x
0.1 x = 99%)
only 1% of the
virus can be
transmitted. If
you reduce
classroom size
to 10% you only
get a 90% virus
reduction. So
with TE 90 masks
and 100%
occupancy you
are ten times
safer.
The first
principle of
dust control is
capture of
contaminants at
the source.
The equation of
20% and 90%
efficient masks
is inexplicable.
Since CATER
masks are
reusable there
can be
sufficient
quantities for
all students
within months.
The biggest
challenge will
be to make sure
that each
student is
provided with a
tight fitting
mask and that he
wears it
appropriately.
A quantitative
fit tester can
cost around
$15K. It can
conduct a test
in just a few
minutes. Testing
30,000 students
would therefore
require 30,000 x
3 min/60 = 1500
hours. So one
tester would be
sufficient to
test all
students several
times per year.
The university
store could have
several fit
testers and fit
testing
services. CATER
masks cost
around $30. So
if the store has
a gross margin
of $10 per mask
and sells 60,000
masks per year,
the margin would
be $600K.
If each fit test
cost $10 then
that would be
major revenue
source. The
masks could have
the school logo
and be sold to
parents,
faculty,
visitors etc.
The university
could also have
a fit testing
instructor
course and offer
it on line to
trainers at
fitness centers
and others who
would also be
conducting fit
testing.
The university
could also be a
leader in
remedying the
misconceptions
about mask
efficiency and
also provide
statistical
analysis
comparing mask
effectiveness to
room occupancy,
disinfection,
HVAC,
partitions.
Countries with
3.3 Billion
People will Only
Achieve a 10%
Vaccination Rate
by the End of
2021
Nearly 70 poor
countries will
only be able to
vaccinate one in
ten people
against COVID-19
next year unless
urgent action is
taken by
governments and
the
pharmaceutical
industry to make
sure enough
doses are
produced, a
group of
campaigning
organizations
warned today, as
the UK begins to
rollout
vaccinations.
By contrast,
wealthier
nations have
bought up enough
doses to
vaccinate their
entire
populations
nearly three
times over by
the end of 2021
if those
currently in
clinical trials
are all approved
for use. Canada
tops the chart
with enough
vaccines to
vaccinate each
Canadian five
times. Updated
data shows that
rich nations
representing
just 14 per cent
of the world's
population have
bought up 53 per
cent of all the
most promising
vaccines so far.
The
organizations,
including
Amnesty
International,
Frontline AIDS,
Global Justice
Now and Oxfam,
who are part of
an alliance
calling for a
People's
Vaccine, used
data collected
by science
information and
analytics
company
Airfinity to
analyze the
deals done
between
countries and
the eight
leading vaccine
candidates. They
found that 67
low and lower
middle-income
countries risk
being left
behind as rich
countries move
towards their
escape route
from this
pandemic. Five
of the 67 -
Kenya, Myanmar,
Nigeria,
Pakistan and
Ukraine - have
reported more
than 1.5 million
cases between
them.
Anna Marriott,
Oxfam's health
policy Manager,
said: "No one
should be
blocked from
getting a
life-saving
vaccine because
of the country
they live in or
the amount of
money in their
pocket. But
unless something
changes
dramatically,
billions of
people around
the world will
not receive a
safe and
effective
vaccine for
COVID-19 for
years to come."
Heidi Chow, from
Global Justice
Now, said: "All
pharmaceutical
corporations and
research
institutions
working on a
vaccine must
share the
science,
technological
know-how, and
intellectual
property behind
their vaccine so
enough safe and
effective doses
can be produced.
Governments must
also ensure the
pharmaceutical
industry puts
people's lives
before profits."
So far, all of
Moderna's doses
and 96 percent
of Pfizer/BioNTech's
have been
acquired by rich
countries. In
welcome contrast
Oxford/AstraZeneca
has pledged to
provide 64
percent of their
doses to people
in developing
nations. Yet
despite their
actions to scale
up supply they
can still only
reach 18 per
cent of the
world's
population next
year at most.
Oxford/AstraZeneca
deals have also
mostly been made
with some of the
big developing
countries like
China and India,
while the
majority of
developing
countries have
not done deals
and have to
share the COVAX
pool of vaccines
between them.
This
demonstrates
that one company
alone cannot
hope to supply
the whole world,
and that only
open sharing of
technology
between vaccine
producers can
make this
possible.
The People's
Vaccine Alliance
is calling on
all
pharmaceutical
corporations
working on
COVID-19
vaccines to
openly share
their technology
and intellectual
property through
the World Health
Organization
COVID-19
Technology
Access Pool, so
that billions
more doses can
be manufactured
and safe and
effective
vaccines can be
available to all
who need them.
The Alliance is
also calling on
governments to
do everything in
their power to
ensure COVID-19
vaccines are
made a global
public
good---free of
charge to the
public, fairly
distributed and
based on need. A
first step would
be to support
South Africa and
India's proposal
to the World
Trade
Organization
Council this
week to waive
intellectual
property rights
for COVID-19
vaccines, tests
and treatments
until everyone
is protected.
Steve Cockburn,
Amnesty
International's
Head of Economic
and Social
Justice, said:
"The hoarding of
vaccines
actively
undermines
global efforts
to ensure that
everyone,
everywhere can
be protected
from COVID-19.
Rich countries
have clear human
rights
obligations not
only to refrain
from actions
that could harm
access to
vaccines
elsewhere, but
also to
cooperate and
provide
assistance to
countries that
need it.
"By buying up
the vast
majority of the
world's vaccine
supply, rich
countries are in
breach of their
human rights
obligations.
Instead, by
working with
others to share
knowledge and
scale up supply,
they could help
bring an end to
the global
COVID-19
crisis."
The vaccines
developed by
AstraZeneca/Oxford,
Moderna and
Pfizer/BioNTech
have received
more than $5
billion dollars
of public
funding, which
the alliance
said placed a
responsibility
on them to act
in the global
public interest.
Dr Mohga Kamal
Yanni, from the
People's Vaccine
Alliance, said:
"Rich countries
have enough
doses to
vaccinate
everyone nearly
three times
over, whilst
poor countries
don't have
enough to even
reach health
workers and
people at risk.
"The current
system, where
pharmaceutical
corporations use
government
funding for
research, retain
exclusive rights
and keep their
technology
secret to boost
profits, could
cost many
lives."
Lois Chingandu,
Director of
Frontline AIDS,
said: "This
pandemic is a
global problem
that requires a
global solution.
The global
economy will
continue to
suffer so long
as much of the
world does not
have access to a
vaccine.
"We need to put
pharmaceutical
industry profit
aside during
this
unprecedented
pandemic, both
to save humanity
and the
economy."
Momentum is
mounting for a
People's
vaccine, which
has already been
backed by COVID
survivors,
health experts,
activists, past
and present
world leaders,
faith leaders
and economists
including Cyril
Ramaphosa, Imran
Khan, Ellen
Johnson Sirleaf,
Gordon Brown,
Helen Clark,
Mary Robinson,
Joseph Stiglitz,
John Nkengasong
and Thomas
Piketty.
Last month in
the US, more
than 100
high-level
leaders from
public health,
faith-based,
racial justice,
and labor
organizations,
joined former
members of
Congress,
economists and
artists to sign a
public letter calling
on
President-elect
Biden seize on
this
extraordinary
moment and power
of the US
President to
support a
People's
Vaccine.
The 67 countries
are:
Afghanistan,
Angola, Algeria,
Benin, Bhutan,
Burundi, Burkina
Faso, Cabo
Verde, Cambodia,
Cameroon,
Central African
Republic, Chad,
Comoros,
Republic of
Congo
(Brazzaville),
Cote d'Ivoire,
Democratic
Republic of
Congo, Djibouti,
Eritrea,
Ethiopia,
Eswatini,
Gambia, Ghana,
The Guinea,
Guinea-Bissau,
Haiti, Kenya,
Kiribati,
Democratic
People's
Republic of
Korea, Kyrgyz
Republic, Lao
PDR, Lesotho,
Liberia,
Madagascar,
Malawi, Mali,
Mauritania,
Micronesia,
Moldova,
Mongolia,
Mozambique,
Myanmar, Niger,
Nigeria,
Pakistan, Papua
New Guinea,
Rwanda, Sao Tome
and Principe,
Senegal, Sierra
Leone, Solomon
Islands,
Somalia, South
Sudan, Sri
Lanka, Sudan,
Syria,
Tajikistan,
Tanzania, Timor
Leste, Togo,
Tunisia, Uganda,
Ukraine,
Vanuatu, West
Bank and Gaza,
Yemen, Zambia,
Zimbabwe.
|